Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to -$3.9 million.

  • Ascendis Pharma A's Cash from Investing Activities fell 86203.75% to -$3.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.7 million, marking a year-over-year decrease of 22939.86%. This contributed to the annual value of -$9.6 million for FY2025, which is 23050.3% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Cash from Investing Activities of -$3.9 million as of Q4 2025, which was down 86203.75% from -$61959.9 recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Cash from Investing Activities registered a high of $226.1 million during Q1 2023, and its lowest value of -$128.0 million during Q4 2021.
  • Its 5-year average for Cash from Investing Activities is $12.3 million, with a median of $3.9 million in 2023.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 98005.78% in 2023, then tumbled by 86203.75% in 2025.
  • Over the past 5 years, Ascendis Pharma A's Cash from Investing Activities (Quarter) stood at -$128.0 million in 2021, then skyrocketed by 99.36% to -$813137.1 in 2022, then surged by 980.06% to $7.2 million in 2023, then tumbled by 105.73% to -$410340.6 in 2024, then plummeted by 862.04% to -$3.9 million in 2025.
  • Its Cash from Investing Activities was -$3.9 million in Q4 2025, compared to -$61959.9 in Q3 2025 and -$4.9 million in Q2 2025.